Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06923943Active Not Recruiting

Predicting Nurse Staffing Requirements From Routinely Collected Data

Role: collaborator

NCT07054047Not ApplicableNot Yet Recruiting

Improving Diagnosis and Treatment for Patients With Rectal Cancer

Role: collaborator

NCT05395871Not ApplicableCompleted

Behavioural Science Messages in Breast Cancer Screening

Role: collaborator

NCT06560931Active Not Recruiting

Defining, Recognising and Escalating Maternal Early Deterioration (DREaMED)

Role: collaborator

NCT05993260Not ApplicableCompleted

Using Text Messages to Boost COVID-19 Vaccine Booking Rate

Role: collaborator

NCT03979222Completed

Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.

Role: collaborator

NCT03253757Unknown

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation

Role: collaborator

All 7 trials loaded